Elevance Health Beats Estimates, Raises Full-Year Adjusted EPS Outlook
Elevance Health reported first-quarter adjusted earnings of $12.58 a share on revenue of $49.5 billion, topping analyst expectations, and raised its full-year adjusted EPS outlook to at least $26.75. The health insurer also said it expects full-year EPS of at least $19.85 and operating cash flow of at least $5.5 billion.
First-quarter revenue rose 1.5% from a year earlier. Adjusted operating margin slipped to 6.5% from 6.7%, while the benefit expense ratio increased 40 basis points to 86.8%. Health Benefits revenue was $42.5 billion and Carelon revenue was $18.0 billion.
From the sources (4 posts)
@wallstengineELEVANCE HEALTH $ELV Q1’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $49.5B (Est. $48.2B) 🟢; +1.5% Y/Y 🔹 Adj. EPS: $12.58 (Est. $10.84) 🟢 🔹 Adj. operating margin: 6.5% (vs 6.7%) 🔹 Benefit expense ratio: 86.8%; +40 bps FY Guide: 🔹 Adj. EPS: at least
@firstsquawkELEVANCEHEALTH Q1 2026 EARNING: ADJ FPS $12.58 (EST $11.00) OPER REV. $49.49B (EST $41.83B) MEDIOAL MEMBERSHIP 45.42M (EST 44.34M) SEES FY ADJ EPS AT LEAST $26.75, SAW AT LEAST $25.50
@businessElevance Health beats Wall Street expectations for the first quarter and raises its full-year guidance as it did a better job of managing medical costs
@alphasenseinc$ELV Earnings: - 1Q 2026 operating revenue of $49.5 billion, up 1.5% from 1Q 2025 - 1Q 2026 diluted EPS of $8.00; adjusted diluted EPS of $12.58 driven by strong operating results and ~$1 per share of non-recurring investment income - FY 2